174 related articles for article (PubMed ID: 2550395)
1. Conservative treatment of uveal melanoma: local recurrence after proton beam therapy.
Munzenrider JE; Verhey LJ; Gragoudas ES; Seddon JM; Urie M; Gentry R; Birnbaum S; Ruotolo DM; Crowell C; McManus P
Int J Radiat Oncol Biol Phys; 1989 Sep; 17(3):493-8. PubMed ID: 2550395
[TBL] [Abstract][Full Text] [Related]
2. Proton beam radiotherapy for uveal melanoma: results of Curie Institut-Orsay proton therapy center (ICPO).
Dendale R; Lumbroso-Le Rouic L; Noel G; Feuvret L; Levy C; Delacroix S; Meyer A; Nauraye C; Mazal A; Mammar H; Garcia P; D'Hermies F; Frau E; Plancher C; Asselain B; Schlienger P; Mazeron JJ; Desjardins L
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):780-7. PubMed ID: 16647221
[TBL] [Abstract][Full Text] [Related]
3. Progress in low-LET heavy particle therapy: intracranial and paracranial tumors and uveal melanomas.
Austin-Seymour M; Munzenrider JE; Goitein M; Gentry R; Gragoudas E; Koehler AM; McNulty P; Osborne E; Ryugo DK; Seddon J
Radiat Res Suppl; 1985; 8():S219-26. PubMed ID: 3003784
[TBL] [Abstract][Full Text] [Related]
4. Conservation treatment of the eye: Conformal proton reirradiation for recurrent uveal melanoma.
Marucci L; Lane AM; Li W; Egan KM; Gragoudas ES; Adams JA; Collier JM; Munzenrider JE
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1018-22. PubMed ID: 16376492
[TBL] [Abstract][Full Text] [Related]
5. Conservative treatment of uveal melanoma: probability of eye retention after proton treatment.
Munzenrider JE; Gragoudas ES; Seddon JM; Sisterson J; McNulty P; Birnbaum S; Johnson K; Austin-Seymour M; Slater J; Goitein MM
Int J Radiat Oncol Biol Phys; 1988 Sep; 15(3):553-8. PubMed ID: 2843486
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of uveal melanoma with iodine 125 plaques or proton beam therapy: indications and comparison of local recurrence rates].
Desjardins L; Lumbroso L; Levy C; Mazal A; Delacroix S; Rosenwald JC; Dendale R; Plancher C; Asselain B
J Fr Ophtalmol; 2003 Mar; 26(3):269-76. PubMed ID: 12746603
[TBL] [Abstract][Full Text] [Related]
7. Intraocular recurrence of uveal melanoma after proton beam irradiation.
Gragoudas ES; Egan KM; Seddon JM; Walsh SM; Munzenrider JE
Ophthalmology; 1992 May; 99(5):760-6. PubMed ID: 1594223
[TBL] [Abstract][Full Text] [Related]
8. Proton radiotherapy as an alternative to exenteration in the management of extended conjunctival melanoma.
Wuestemeyer H; Sauerwein W; Meller D; Chauvel P; Schueler A; Steuhl KP; Bornfeld N; Anastassiou G
Graefes Arch Clin Exp Ophthalmol; 2006 Apr; 244(4):438-46. PubMed ID: 16133022
[TBL] [Abstract][Full Text] [Related]
9. Proton beam radiotherapy versus fractionated stereotactic radiotherapy for uveal melanomas: A comparative study.
Weber DC; Bogner J; Verwey J; Georg D; Dieckmann K; Escudé L; Caro M; Pötter R; Goitein G; Lomax AJ; Miralbell R
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):373-84. PubMed ID: 16168832
[TBL] [Abstract][Full Text] [Related]
10. Proton beam radiotherapy of uveal melanoma: Italian patients treated in Nice, France.
Mosci C; Mosci S; Barla A; Squarcia S; Chauvel P; Iborra N
Eur J Ophthalmol; 2009; 19(4):654-60. PubMed ID: 19551683
[TBL] [Abstract][Full Text] [Related]
11. Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma.
Gragoudas ES; Lane AM; Munzenrider J; Egan KM; Li W
Trans Am Ophthalmol Soc; 2002; 100():43-8; discussion 48-9. PubMed ID: 12545676
[TBL] [Abstract][Full Text] [Related]
12. Uveal melanomas. Conservation treatment.
Munzenrider JE
Hematol Oncol Clin North Am; 2001 Apr; 15(2):389-402. PubMed ID: 11370500
[TBL] [Abstract][Full Text] [Related]
13. Clinical application of proton beams in the treatment of uveal melanoma: the first therapies carried out in Italy and preliminary results (CATANA Project).
Spatola C; Privitera G; Raffaele L; Salamone V; Cuttone G; Cirrone P; Sabini MG; Lo Nigro S
Tumori; 2003; 89(5):502-9. PubMed ID: 14870772
[TBL] [Abstract][Full Text] [Related]
14. Linear accelerator-based stereotactic fractionated photon radiotherapy as an eye-conserving treatment for uveal melanoma.
Akbaba S; Foerster R; Nicolay NH; Arians N; Bostel T; Debus J; Hauswald H
Radiat Oncol; 2018 Aug; 13(1):140. PubMed ID: 30071857
[TBL] [Abstract][Full Text] [Related]
15. Cataract development in patients treated with proton beam therapy for uveal melanoma.
Seibel I; Cordini D; Hager A; Riechardt AI; Rehak M; Böker A; Böhmer D; Heufelder J; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2016 Aug; 254(8):1625-1630. PubMed ID: 27116211
[TBL] [Abstract][Full Text] [Related]
16. Salvage proton beam therapy in local recurrent uveal melanoma.
Riechardt AI; Cordini D; Dobner B; Seibel I; Gundlach E; Rehak M; Hager A; Stark R; Moser L; Joussen AM
Am J Ophthalmol; 2014 Nov; 158(5):948-56. PubMed ID: 25038327
[TBL] [Abstract][Full Text] [Related]
17. Proton therapy of uveal melanomas in Berlin. 5 years of experience at the Hahn-Meitner Institute.
Höcht S; Bechrakis NE; Nausner M; Kreusel KM; Kluge H; Heese J; Heufelder J; Cordini D; Homeyer H; Fuchs H; Martus P; Foerster MH; Wiegel T; Hinkelbein W
Strahlenther Onkol; 2004 Jul; 180(7):419-24. PubMed ID: 15241529
[TBL] [Abstract][Full Text] [Related]
18. Estimates of ocular and visual retention following treatment of extra-large uveal melanomas by proton beam radiotherapy.
Conway RM; Poothullil AM; Daftari IK; Weinberg V; Chung JE; O'Brien JM
Arch Ophthalmol; 2006 Jun; 124(6):838-43. PubMed ID: 16769837
[TBL] [Abstract][Full Text] [Related]
19. Proton beam therapy for the treatment of uveal melanoma in Scotland.
Macdonald EC; Cauchi P; Kemp EG
Br J Ophthalmol; 2011 Dec; 95(12):1691-5. PubMed ID: 21216794
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.
Böker A; Pilger D; Cordini D; Seibel I; Riechardt AI; Joussen AM; Bechrakis NE
Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1767-1775. PubMed ID: 29907945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
